We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Karus Announces First Lymphoma Patients Dosed with KA2237 in Clinical Study

News   Oct 06, 2016

 
Karus Announces First Lymphoma Patients Dosed with KA2237 in Clinical Study
 
 
 

RELATED ARTICLES

Vitamin D Metabolites Influence T Cell Priming

News

Fresh insights on the effect of vitamin D on the immune system add to the greater picture of how vitamin D might influence susceptibility to inflammatory diseases.

READ MORE

Gene Therapy Restores Immunity in Infants With Rare Immunodeficiency Disease

News

A small clinical trial has shown that gene therapy can safely correct the immune systems of infants newly diagnosed with a rare, life-threatening inherited disorder in which infection-fighting immune cells do not develop or function normally.

READ MORE

Guarding Against Cancer

News

Researchers from the University of Dundee have shown that a drug previously used to treat Type II diabetes could potentially be used to protect against cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE